AACR to Ring Opening Bell at NASDAQ Stock Market
PHILADELPHIA – The American Association for Cancer Research’s Chief Executive Officer, Margaret Foti, Ph.D., M.D. (h.c.), along with other AACR representatives, rang the opening bell at the NASDAQ Stock Market on Tuesday, August 3, signaling the start of the day’s trading. The ceremony was broadcast live on a seven-story video tower in New York City’s Times Square, and streamed live on the Internet. A recording of the event will soon be available.
“We are delighted to have this extraordinary opportunity to ring the opening bell of the NASDAQ Stock Market and thereby raise the public’s awareness about the vital role that research plays in saving lives from cancer,” said Foti. “This is an exciting time for cancer research. The pace of cutting-edge breakthroughs in the cancer field is very impressive, but more work needs to be done to bring these discoveries to patients everywhere. Scientific research is critical to treating and preventing the more than 200 diseases we call cancer, and it is thrilling that we are able to share this important message with the financial community and the public.”
NASDAQ is the world’s largest stock exchange company, listing more than 3,600 companies around the globe.
View pictures of the event:
Download additional photos:
# # #
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 32,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowship and career development awards. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.